20D0 DCF Valuation - Cidara Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 183 EUR Market Closed

Market Cap: €5.8B

	Cidara Therapeutics Inc F:20D0	US
A	Allstate Corp XBER:ALS	US
	Thomson Reuters Corp TSX:TRI	CA
	Silvercorp Metals Inc TSX:SVM	CA
	China Development Financial Holding Corp TWSE:2883B	TW
	Koninklijke Ahold Delhaize NV F:AHOG	NL
B	Bellerophon Therapeutics Inc F:6L7A	US
M	MSCI Inc XBER:3HM	US
A	Advanced Micro Devices Inc MIL:AMD	US

20D0's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

Continue 20D0 Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

CDTX

F • EUR

20D

SWB • EUR

20D

Join 346,100+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.